Adamis Pharmaceuticals Corp. (ADMP) Stock Surges Following Promising News of TEMPOL as Potential Covid-19 Treatment
AdamisPharmaceuticals Corp. (ADMP) stock prices were up by a significant 17.84% shortly after market trading commenced on June 7th, 2021, bringing the price per share up to USD$1.1784 early on in the trading day. TEMPOL The company announced on June 7th, 2021 that the National Institute of Health (NIH) had identified the company’s proprietary experimental […]
